Header Logo

Connection

GRACE LO to Androgen Antagonists

Back to Details
This is a "connection" page, showing publications GRACE LO has written about Androgen Antagonists.
GRACE LO
Connection Strength
0.041
Androgen Antagonists
  1. Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial. Ann Oncol. 2021 07; 32(7):896-905.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.